Moderna Gets Further $472 Million US Award for Coronavirus Vaccine Development

The drug maker said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of Moderna's vaccine candida.

from Top Business News- News18.com https://ift.tt/2DcOHSf

• Tweet
• Share
• Share
• Share
• Share